top of page

StroMed™ Cell Therapy

A patented stem-cell therapy developed in Australia. Validated by clinical research, and delivered at the point of care.

StroMed

Why adipose-derived stem cellsy

Adipose tissue is one of the richest and most accessible sources of regenerative cells in the body. Six reasons it sits at the heart of StroMed.

01

Abundance of cells

Compared to other sources such as bone marrow, adipose tissue provides a higher yield of cells, making it easier and more cost-effective to obtain a sufficient number of cells for clinical use.

02

High Concentration of Regenerative Cell types

Adipose tissue contains a high concentration of mesenchymal stem cells (ASCs), which have the ability to differentiate into a wide range of cell types such as bone, cartilage, and muscle.

03

Low Risk of Rejection

Autologous adipose tissue has a low risk of rejection, making it a safe source of stem cells for transplantation.

04

Versatility

SVF have shown promising results in treating a variety of conditions such as osteoarthritis, myocardial infarction, and neurological disorders.

05

Easy Accessibility

Adipose tissue is easily accessible, making it a convenient source of stem cells.

06

Immunomodulatory

Comparison studies conclude Ad MSC superior to BM-MSC with stronger immunosuppressive capabilities. Mattar 2015 et al.

Cutting-Edge StroMed  Cell Therapy Technology

Cell Innovations has developed and patented a unique and disruptive process to separate SVF from patient fat tissue using ultrasonic cavitation at the point of care.

stromed-process-modern-artarmon.jpg
bottom of page